Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.


TSX:SZLS - Post by User

Post by Liked2Thinkon Mar 30, 2021 2:19pm
131 Views
Post# 32907145

So we have 1 Day left then?

So we have 1 Day left then?Tripp has until tomorrow to keep his word about releasing Aristotle Q1 then right.

Can anyone remember when a date was met with this company though?

Lets face it, its not going to happen even on the last day of Q1.  Another promise not kept.

Seems to me it was an easy one to keep though.  Technically you just have to release it you dont have to start doing the test or collecting payments. its a formality.

Why would a company release news on a wednesday before a long weekend though doesnt make sense.

I guess i just wish Trip had said it was coming for Q2 instead.

So much to look forward with this company and they just cant do the simple things of doing what they say.

Im still holding out hope he is waiting to the end to prove the naysayers wrong but its hard to bet on that anymore.
<< Previous
Bullboard Posts
Next >>